Paul L. Beaumier

Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Steven M. Larson, Jorge A. Carrasquillo, K Krohn et al. · Journal of Clinical Investigation · 1983 · 262 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations

Medicine, Oncology, Pharmacology +17

Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

Jorge A. Carrasquillo, K. A. Krohn, Paul L. Beaumier et al. · PubMed · 1984 · 183 citations

Life Sciences, Immunology, Oncology +17

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Alan R. Fritzberg, Paul G. Abrams, Paul L. Beaumier et al. · Proceedings of the National Academy of Sciences · 1988 · 161 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacology +17

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

Hazel B. Breitz, Paul L. Weiden, Paul L. Beaumier et al. · PubMed · 2000 · 151 citations

Medicine, Nuclear Medicine, Oncology +17